Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer

SAN DIEGO, Dec. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, announced today the appointment of Timothy C. Rodell, M.D., FCCP, as Inte... Devices, Oncology, Personnel Aethlon Medical, Hemopurifier, immunotherapeutic
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news